We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$438B
AUM Growth
+$25.1B
Cap. Flow
-$8.15B
Cap. Flow %
-1.86%
Top 10 Hldgs %
17.51%
Holding
4,666
New
116
Increased
1,932
Reduced
2,096
Closed
202

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$612M
2
AAPL icon
Apple
AAPL
+$402M
3
HUBB icon
Hubbell
HUBB
+$281M
4
ADP icon
Automatic Data Processing
ADP
+$246M
5
ECL icon
Ecolab
ECL
+$244M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 15.04%
3 Financials 12.69%
4 Industrials 9.18%
5 Consumer Discretionary 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCLI
4176
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$19.7K ﹤0.01%
800
+31
+4% +$1.16K
ICAD
4177
DELISTED
iCAD Inc
ICAD
$19.5K ﹤0.01%
10,661
IKT icon
4178
Inhibikase Therapeutics
IKT
$378M
$19.5K ﹤0.01%
6,501
-51
-0.8% -$202
ZYNE
4179
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$19.4K ﹤0.01%
36,662
-81
-0.2% -$51
CATX icon
4180
Perspective Therapeutics
CATX
$354M
$19.1K ﹤0.01%
7,723
CNF
4181
CNFinance Holdings
CNF
$41M
$18.9K ﹤0.01%
1,104
PASG icon
4182
Passage Bio
PASG
$14.7M
$18.8K ﹤0.01%
682
VISL
4183
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$18.6K ﹤0.01%
1,662
VIRX
4184
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$18.5K ﹤0.01%
12,681
-46
-0.4% -$134
CURI icon
4185
CuriosityStream
CURI
$237M
$18.4K ﹤0.01%
16,171
AVCT
4186
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$18.3K ﹤0.01%
15,939
+1
+0% +$1
MCHX icon
4187
Marchex
MCHX
$80.6M
$18K ﹤0.01%
11,245
ONCT
4188
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$17.6K ﹤0.01%
880
SNTI icon
4189
Senti Biosciences Holdings
SNTI
$12M
$17.4K ﹤0.01%
+1,237
New +$30.2K
ONCR
4190
DELISTED
Oncorus, Inc.
ONCR
$16.8K ﹤0.01%
66,498
-497
-0.7% -$283
WORX
4191
DELISTED
SCWORX CORP NEW
WORX
$16.6K ﹤0.01%
187
-1
-0.5% -$127
BOLT icon
4192
Bolt Biotherapeutics
BOLT
$6.17M
$16.4K ﹤0.01%
631
-3
-0.5% -$82
GLS
4193
DELISTED
Gelesis Holdings, Inc.
GLS
$16.2K ﹤0.01%
55,884
SLE icon
4194
Super League Enterprise
SLE
$5.41M
$16.2K ﹤0.01%
5
CYPH
4195
Cypherpunk Technologies Inc
CYPH
$69.8M
$16K ﹤0.01%
3,548
NVVE
4196
DELISTED
Nuvve Holding Corp
NVVE
0
TCDA
4197
DELISTED
Tricida, Inc. Common Stock
TCDA
$15.8K ﹤0.01%
103,049
+1,815
+2% +$5.4K
TGB
4198
Trekor Metals
TGB
$3.08B
$15.7K ﹤0.01%
10,711
SCTL
4199
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$15.7K ﹤0.01%
10,526
DYAI icon
4200
Dyadic International
DYAI
$28.1M
$15.5K ﹤0.01%
12,574

Similar funds

Bank of New York Mellon's Q4 2022 Portfolio in Review

As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
  • Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
  • Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
  • Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
  • Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
  • Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
  • Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.